Jim Ackland

415 total citations
10 papers, 259 citations indexed

About

Jim Ackland is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jim Ackland has authored 10 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Jim Ackland's work include HIV Research and Treatment (5 papers), Viral gastroenteritis research and epidemiology (3 papers) and Virus-based gene therapy research (3 papers). Jim Ackland is often cited by papers focused on HIV Research and Treatment (5 papers), Viral gastroenteritis research and epidemiology (3 papers) and Virus-based gene therapy research (3 papers). Jim Ackland collaborates with scholars based in United States, United Kingdom and Australia. Jim Ackland's co-authors include Michael A. Steller, Masaru Murakami, Francesco M. Marincola, Amanda Handley, Wayne C. Koff, Ian D. Gust, Hans Gelderblom, Hana Hassanin, Philip R. Johnson and Len Dally and has published in prestigious journals such as PLoS ONE, The Lancet Infectious Diseases and Journal of Immunological Methods.

In The Last Decade

Jim Ackland

9 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jim Ackland United States 6 93 90 81 80 67 10 259
Chaobaihui Ye United States 6 145 1.6× 55 0.6× 158 2.0× 170 2.1× 53 0.8× 7 354
Eddy Sayeed United States 5 65 0.7× 62 0.7× 132 1.6× 105 1.3× 65 1.0× 7 235
Romnie Long United States 8 150 1.6× 95 1.1× 151 1.9× 107 1.3× 62 0.9× 11 307
Thomas N. Denny United States 8 132 1.4× 43 0.5× 70 0.9× 76 0.9× 30 0.4× 11 226
J F Zagury France 8 153 1.6× 73 0.8× 230 2.8× 82 1.0× 81 1.2× 9 326
Veronica Iannucci Belgium 7 157 1.7× 60 0.7× 215 2.7× 102 1.3× 109 1.6× 9 337
Shara N. Pantry United States 6 44 0.5× 179 2.0× 60 0.7× 80 1.0× 77 1.1× 6 330
Anouk Van Nuffel Belgium 6 142 1.5× 64 0.7× 229 2.8× 97 1.2× 109 1.6× 8 324
Lisa Egerer Austria 7 54 0.6× 52 0.6× 61 0.8× 186 2.3× 88 1.3× 8 339
Brigitte Müllauer Austria 9 234 2.5× 45 0.5× 89 1.1× 50 0.6× 48 0.7× 12 339

Countries citing papers authored by Jim Ackland

Since Specialization
Citations

This map shows the geographic impact of Jim Ackland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Ackland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Ackland more than expected).

Fields of papers citing papers by Jim Ackland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Ackland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Ackland. The network helps show where Jim Ackland may publish in the future.

Co-authorship network of co-authors of Jim Ackland

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Ackland. A scholar is included among the top collaborators of Jim Ackland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Ackland. Jim Ackland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sharma, Vaneet K., Sergey Menis, Evan T. Brower, et al.. (2024). Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate. Pharmaceutics. 16(6). 742–742. 2 indexed citations
2.
Witte, Desirée, Amanda Handley, Khuzwayo C. Jere, et al.. (2022). Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study. The Lancet Infectious Diseases. 22(5). 668–678. 15 indexed citations
5.
Priddy, Frances, David Lewis, Hans Gelderblom, et al.. (2019). Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial. The Lancet HIV. 6(4). e230–e239. 105 indexed citations
6.
Kløverpris, Henrik N., Akil Jackson, Amanda Handley, et al.. (2013). Non-Immunogenicity of Overlapping Gag Peptides Pulsed on Autologous Cells after Vaccination of HIV Infected Individuals. PLoS ONE. 8(10). e74389–e74389. 2 indexed citations
7.
Excler, Jean‐Louis, et al.. (2010). Replicating viral vectors as HIV vaccines: Summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference. Biologicals. 38(4). 511–521. 24 indexed citations
8.
Kløverpris, Henrik N., Anders Fomsgaard, Amanda Handley, et al.. (2010). Dimethyl sulfoxide (DMSO) exposure to human peripheral blood mononuclear cells (PBMCs) abolish T cell responses only in high concentrations and following coincubation for more than two hours. Journal of Immunological Methods. 356(1-2). 70–78. 38 indexed citations
9.
Koff, Wayne C., et al.. (2008). Replicating viral vectors as HIV vaccines. Biologicals. 36(5). 277–286. 16 indexed citations
10.
Murakami, Masaru, et al.. (1999). Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells.. PubMed. 59(6). 1184–7. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026